Acute chest pain (ACP) is a common yet challenging presentation in emergency departments. The differential diagnosis is broad, ranging from benign conditions to life-threatening emergencies. This article aims to provide a comprehensive guide to the clinical approach to ACP, assisting healthcare professionals in making accurate diagnoses and managing patients effectively.
ACP necessitates immediate triage and evaluation. Key aspects include a detailed history, physical examination, and initial investigations. The history should focus on the character, onset, location, duration, and radiation of the pain. Associated symptoms such as dyspnea, diaphoresis, nausea, or syncope should be noted. Physical examination should assess vital signs, cardiac and respiratory systems, and potential sources of referred pain.
Electrocardiogram (ECG) is the first-line investigation for ACP. It can reveal myocardial ischemia, infarction, or arrhythmias. Serial cardiac biomarkers are also crucial in diagnosing myocardial damage. Additional investigations like chest X-ray, computed tomography (CT), or echocardiography may be required based on the clinical suspicion.
Management should be tailored to the underlying cause of ACP. For suspected acute coronary syndrome (ACS), immediate reperfusion therapy is recommended. This may include pharmacological therapy with antiplatelets and anticoagulants, or invasive strategies like percutaneous coronary intervention (PCI). Non-cardiac causes should be managed according to their specific treatment guidelines.
Risk stratification is essential to guide management and disposition of patients with ACP. Tools like the HEART score can help in assessing the risk of major adverse cardiac events. High-risk patients require intensive care, while low-risk patients may be suitable for outpatient management or further testing.
The clinical approach to ACP requires a systematic evaluation, judicious use of diagnostic modalities, and tailored treatment strategies. Risk stratification plays a pivotal role in managing these patients. Ongoing education and adherence to evidence-based guidelines can ensure optimal patient outcomes in this critical clinical scenario.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation